Sign in

CIK 0001668243

  • Non-accelerated filer
  • Smaller reporting company

UroGen Pharma Ltd.

Sign in to watch
Ticker
URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 97707601
Business address
9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$182,793
in 3 filings

Net −$182,793. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 8 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-01-31 PFREUNDSCHUH PETER P. Chief Financial Officer Grant or award · Restricted Stock Unit +6,000 6,000
2020-01-31 Mullennix Stephen Chief Operating Officer Grant or award · Stock options (right to buy) +15,000 15,000
2020-01-31 Mullennix Stephen Chief Operating Officer Grant or award · Restricted stock unit +3,000 3,000
2020-01-31 Schoenberg Mark Chief Medical Officer Grant or award · Stock options (right to buy) +15,000 15,000
2020-01-31 Schoenberg Mark Chief Medical Officer Grant or award · Restricted stock unit +6,000 6,000
2020-01-31 Barrett Elizabeth A. Chief Executive Officer Grant or award · Stock options (right to buy) +45,000 45,000
2020-01-31 Barrett Elizabeth A. Chief Executive Officer Grant or award · Restricted Stock Unit +15,000 15,000
2020-01-27 PFREUNDSCHUH PETER P. Chief Financial Officer Sale −667 $29.28 $20K 4,438
2020-01-27 Mullennix Stephen Chief Operating Officer Sale −684 $29.26 $20K 8,665
2020-01-27 Schoenberg Mark Chief Medical Officer Sale −322 $29.15 $9K 9,177
2020-01-26 PFREUNDSCHUH PETER P. Chief Financial Officer Exercise or conversion +1,666 5,105
2020-01-26 PFREUNDSCHUH PETER P. Chief Financial Officer Exercise or conversion · Restricted Stock Units (RSUs) −1,666 3,334
2020-01-26 Mullennix Stephen Chief Operating Officer Exercise or conversion +1,666 9,349
2020-01-26 Mullennix Stephen Chief Operating Officer Exercise or conversion · Restricted Stock Units (RSUs) −1,666 3,334
2020-01-26 Schoenberg Mark Chief Medical Officer Exercise or conversion +833 9,499
2020-01-26 Schoenberg Mark Chief Medical Officer Exercise or conversion · Restricted Stock Units (RSUs) −833 1,667
2020-01-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion +105,688 122,236
2020-01-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion · Ordinary Shares −105,688 211,377
2019-12-04 Schoenberg Mark Chief Medical Officer Exercise or conversion +1,042 9,009
2019-12-04 Schoenberg Mark Chief Medical Officer Shares withheld for taxes −343 $31.69 $11K 8,666

Page 23 of 25 · 496 trades